HCA Healthcare Inc (NYSE: HCA) started the day on Wednesday, with a price increase of 0.46% at $410.03, before settling in for the price of $408.17 at the close. Taking a more long-term approach, HCA posted a 52-week range of $215.96-$417.14.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 6.95%. Meanwhile, its Annual Earning per share during the time was 12.21%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 18.28%. This publicly-traded company’s shares outstanding now amounts to $265.54 million, simultaneously with a float of $185.65 million. The organization now has a market capitalization sitting at $105.82 billion. At the time of writing, stock’s 50-day Moving Average stood at $394.25, while the 200-day Moving Average is $339.73.
HCA Healthcare Inc (HCA) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Medical Care Facilities Industry. HCA Healthcare Inc’s current insider ownership accounts for 28.06%, in contrast to 65.29% institutional ownership. According to the most recent insider trade that took place on Sep 12 ’24, this organization’s EVP and Chief Clinical Officer sold 8,358 shares at the rate of 385.42, making the entire transaction reach 3,221,340 in total value, affecting insider ownership by 29,678.
HCA Healthcare Inc (HCA) Earnings and Revenue Records
HCA Healthcare Inc’s EPS increase for this current 12-month fiscal period is 18.28% and is forecasted to reach 24.96 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 12.00% through the next 5 years, which can be compared against the 12.21% growth it accomplished over the previous five years trading on the market.
HCA Healthcare Inc (NYSE: HCA) Trading Performance Indicators
Let’s observe the current performance indicators for HCA Healthcare Inc (HCA). It’s Quick Ratio in the last reported quarter now stands at 0.94. The Stock has managed to achieve an average true range (ATR) of 8.36. Alongside those numbers, its PE Ratio stands at $19.24, and its Beta score is 1.67. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.55. Similarly, its price to free cash flow for trailing twelve months is now 21.65.
In the same vein, HCA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 21.31, a figure that is expected to reach 4.96 in the next quarter, and analysts are predicting that it will be 24.96 at the market close of one year from today.
Technical Analysis of HCA Healthcare Inc (HCA)
If we take a close look at the recent performances of HCA Healthcare Inc (NYSE: HCA), its last 5-days Average volume was 1.01 million that shows plunge from its year to date volume of 1.14 million. During the previous 9 days, stock’s Stochastic %D was recorded 77.29% While, its Average True Range was 8.40.
Raw Stochastic average of HCA Healthcare Inc (HCA) in the period of the previous 100 days is set at 93.20%, which indicates a major rise in contrast to 84.77% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 22.96% that was higher than 22.46% volatility it exhibited in the past 100-days period.
